Keywords
Exploration
Accueil
Racine
Exploration
Accueil
Racine

La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Keywords » - entrée « 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (adverse effects) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (administration & dosage) < 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (adverse effects) < 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (analogs & derivatives)  Facettes :

List of bibliographic references indexed by 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (adverse effects)

Number of relevant bibliographic references: 10.
Ident.Authors (with country if any)Title
001646 (2011) Arman Lira ; Jerzy Kulczycki ; Ruth Slack ; Hymie Anisman ; David S. ParkInvolvement of the Fcγ Receptor in a Chronic N-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Mouse Model of Dopaminergic Loss*
001E06 (2009) Mélanie Bourque [Canada] ; Dean E. Dluzen ; Thérèse Di PaoloNeuroprotective actions of sex steroids in Parkinson's disease.
002317 (2008) Patrick L. Mcgeer [Canada] ; Edith G. Mcgeer [Canada]Glial reactions in Parkinson's disease
002F47 (2003) Nancy Belanger [Canada] ; Laurent Gregoire [Canada] ; ABDALLAH HADJ TAHAR [Canada] ; Paul J. Bedard [Canada]Chronic treatment with small doses of cabergoline prevents Dopa-induced dyskinesias in Parkinsonian monkeys
003567 (2000) B. J. Snow [Canada] ; F. J. G. Vingerhoets [Canada] ; J. W. Langston [États-Unis] ; J. W. Tetrud [États-Unis] ; V. Sossi [Canada] ; D. B. Calne [Canada]Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonism
003625 (1999) R. Grondin [Canada] ; V D Doan ; L. Grégoire ; P J BédardD1 receptor blockade improves L-dopa-induced dyskinesia but worsens parkinsonism in MPTP monkeys.
003839 (1999) R. Grondin [Canada] ; P. J. Bedard [Canada] ; A. Hadj Tahar [Canada] ; L. Gregoire [Canada] ; A. Mori [Japon] ; H. Kase [Japon]Antiparkinsonian effect of a new selective adenosine A2A receptor antagonist in MPTP-treated monkeys
004224 (1994) F. J. G. Vingerhoets [Canada] ; B. J. Snow [Canada] ; J. W. Tetrud [États-Unis] ; J. W. Langston [États-Unis] ; M. Schulzer [Canada] ; M. Calne [Canada]Positron emission tomographic evidence for progression of human MPTP‐induced dopaminergic lesions
004828 (1991) O. S. Kofman [Canada]Deprenyl : protective vs. symptomatic effect
005658 (????) V. Sossi [Canada] ; M W Stazyk ; P E Kinahan ; T J RuthBasal ganglia studies with 3D acquisition and 2D reconstruction on a retractable septa PET scanner.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (adverse effects)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (adverse effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (adverse effects)
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022